Novel mutation leading to splice donor loss in a conserved site of DMD gene causes Duchenne muscular dystrophy with cryptorchidism

In a landmark study, our team has unveiled crucial insights into cryptorchidism, a prevalent male birth defect where testicles do not descend properly. By examining the genetic blueprint of affected individuals, we identified new and known genes linked to this condition, primarily on the X chromosome, suggesting a pattern of inheritance from the mother. This […]

Read More…

Pathogenic variant detection rate varies considerably in Male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2

Male breast cancer (MBC) affects around 1 in 1000 men and is known to have a higher underlying cause from high and moderate risk gene pathogenic variants (PV) than female breast cancer, particularly in BRCA2. However, most studies only report overall detection rates without assessing detailed family history. We reviewed genetic testing in 204 families […]

Read More…

BRCA awareness and testing experience in the UK Jewish population: a qualitative study

Jewish people have a higher risk of carrying an alteration in the BRCA genes, which cause breast and ovarian cancer. This is the first UK study to explore Jewish peoples’ experiences of genetic-testing. We interviewed 32 people, and found that nobody regretted having testing, although there was huge variation in satisfaction. Many people had issues […]

Read More…

Phenotypic characterisation of SMAD4 variant carriers

In this observational study, we describe the phenotype of 33 patients carrying SMAD4 variants. Both hereditary haemorrhagic telangiectasia (HHT), a rare vascular genetic disease, and juvenile polyposis syndrome (JPS), a rare precancerous condition that confers an increased risk of developing gastrointestinal cancers, are known to be caused by SMAD4 pathogenic variants. Given SMAD4’s crucial role […]

Read More…

Subcellular localisation of truncated MAGEL2 proteins: insight into the molecular pathology of Schaaf-Yang syndrome

Our research focuses on Schaaf-Yang syndrome (SYS), an ultra rare neurodevelopmental disease caused by truncating mutations in the MAGEL2 gene. Particularly, in this study we explore how these mutations affect the localization of the MAGEL2 protein within cells. By heterologous expression of tagged proteins we found that the truncated forms tend to accumulate more in […]

Read More…

A comparative medical genomics approach may facilitate the interpretation of rare missense variation

This study compares rare genetic variation in humans and in nine domestic animal species. We found that variants causing disease in these non-human animals tend to also cause disease in humans. The findings suggest that data from DNA sequencing in veterinary medicine could aid in interpreting rare genetic variation seen in the clinic. Our results […]

Read More…

ZFHX3 variants cause childhood partial epilepsy and infantile spasms with favorable outcomes

Epilepsy is a common neurological disorder with age-dependent seizures, which includes developmental and epileptic encephalopathy (DEE), a severe form of epilepsy. This study identified ZFHX3 as a pathogenic gene of DEE and partial epilepsy. All patients with ZFHX3 variants achieved seizure-free after appropriate treatment. Studies in fly, mouse, and human all showed that ZFHX3 is highly expressed in the embryonic stage and decreased dramatically […]

Read More…

Biallelic variants in Plexin B2 (PLXNB2) cause amelogenesis imperfecta, hearing loss and intellectual disability

Plexins are receptors for Semaphorin signalling proteins. Semaphorin-plexin signalling controls cellular interactions that are critical during development and in adult life stages. We identified biallelic variants in Plexin B2 (PLXNB2) through exome or genome sequencing in eight people from six families, each of whom have a syndromic condition including amelogenesis imperfecta and hearing loss. Intellectual […]

Read More…

Survey of service needs to embed genome sequencing for motor neuron disease in neurology in the English National Health Service

Everyone with MND in England is now eligible for a test to see if their MND is linked to their genes, i.e. genome sequencing. We surveyed 245 neurology and genetics clinicians about their genetic knowledge, experience and training. Neurology clinicians reported multiple barriers to offering genome sequencing. Further, they rated their confidence in genetics knowledge […]

Read More…

Dissecting Genetic Architecture of Rare Dystonia: Genetic, Molecular and Clinical Insights

Dystonia is one of the most common movement disorders. This is the first study that covers dystonia families from Turkey, the population of which is known to be a mixture of populations from the Middle East, the Caucasus, the Balkans, Central Asia, and Europe. We identified potentially disease-causing variants in the established dystonia genes (PRKRA, […]

Read More…